The observed accumulation of St-PGA-OG-mUNO in the tumor core (Fig. 2T, TC) and receptor colocalization (Fig. 2U), supported the implementation of our platform as an efficient alternative to antibody-based therapies such as anti-PDL1 or antibody–drug conjugates. This evidence concerns the gene CD274 and neoplasm.